The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...

This is why UNAIDS is launching the development of the new Global AIDS Strategy 2026-2031, an ambitious, inclusive, and action-driven plan that will guide the global HIV response for the next five ...

Because South Africa has the world's largest population of people living with HIV, at more than 8 million, it is a hub for research on the virus. "Most of the landmark and groundbreaking studies have ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...

The HIV/AIDS treatment programme is "currently under threat because of the Trump administration disbanding and abandoning ...

The Ministry of Health warns that the freeze has exposed critical services such as HIV management, vaccine programs, ...

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

Pharmaceutical companies have been at the forefront of advances in medical innovation that are leading to real improvements in the health of people worldwide. These advances are also supporting ...

Trump’s aid cut has also hit clinical trials. The South African Medical Research Council, which was awarded $45 million to ...